CXCL10 and COVID-19: Runfeng et al. confirmed that Lianhua Qingwen drastically inhibited novel SARS-CoV-2 replication in Vero E6 cells, which significantly decreased numerous inflammatory cytokines such as TNF-α, CXCL-10/IP-10, and IL-6 at mRNA level, which could be a new promising method to control COVID-19 [65].